• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INOGEN X4 CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INOGEN X4 CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G146
Device Problems Failure to Charge (1085); Failure to Convert Rhythm (1540); Failure to Read Input Signal (1581); Under-Sensing (1661); Low impedance (2285); Defective Device (2588)
Patient Problem Insufficient Information (4580)
Event Date 07/23/2023
Event Type  Death  
Manufacturer Narrative
The device has been returned for analysis.This report will be updated upon completion of analysis.
 
Event Description
It was reported that this patient passed away.The patients obituary indicates the patient passed away at home.Boston scientific technical services (ts) reviewed data from the patients implanted cardiac resynchronization therapy defibrillator (crt-d) device.There was a stored episode where the device provided three rounds of anti-tachycardia pacing (atp) therapy followed by a 41 joule device shock for a ventricular arrhythmia.The device shock exhibited an associated shock fault due to a low out of range right ventricular (rv) lead shock impedance value.The shock impedance value was reported as less than 20 ohms, which means the measured shock impedance was less than the minimum value, too low for a numerical result.The device subsequently attempted 26 times to charge for an additional shock, but all attempts failed, exhibiting shock faults and aborted shock attempts due to high voltage and the episode ended.There were 10 subsequent non-sustained ventricular episodes where no device therapy was provided.Ts noted that these stored episodes showed an agonal rhythm and functional undersensing of the degrading electrical signal.Boston scientific engineering also reviewed the stored episode with device therapy.Engineering indicated that the 41 joule shock appears to have damaged the crt-d device resulting in the numerous subsequent high voltage faults during attempted charging.The internal damage resulted in energy leakage during charging which the device sensed as external energy, even though there were no external shock attempts.It was recommended that the crt-d device and rv lead be returned to boston scientific for analysis.The crt-d device and rv lead were returned and have been received at boston scientific.
 
Manufacturer Narrative
The device has been returned for analysis.This report will be updated upon completion of analysis.Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the device was performed.A review of device memory confirmed that the device delivered a 41 joule shock but exhibited an associated shock fault due to a low out of range right ventricular (rv) lead shock impedance value of less than 20 ohms.Device memory also confirmed there were numerous high voltage faults during subsequent attempts by the device to charge.Microscopic inspection of the device noted an electrical arcing mark on the outer device case just below the device header.An x-ray of the device indicated that the internal plasma fuse component was blown open.The device is unable to charge with an open plasma fuse.The proximal segment of the associated rv lead was also returned for analysis and there was observed inner insulation, outer insulation, and conductor damage consistent with the lead being crushed.There was no evidence observed of electrical arcing damage or melted metal on the lead segment.However, it is likely, based on the electrical arcing mark observed on the outer case of the device and the observed damage of the returned rv lead segment, that electrical arcing did occur in the damaged lead area during the attempted device shock and resulted in damage to the internal device plasma fuse.Laboratory analysis indicates the reported clinical observations were caused by damaged lead insulation and lead conductors, which then caused internal damage to the device plasma fuse during the device shock.
 
Event Description
It was reported that this patient passed away.The patients obituary indicates the patient passed away at home.Boston scientific technical services (ts) reviewed data from the patients implanted cardiac resynchronization therapy defibrillator (crt-d) device.There was a stored episode where the device provided three rounds of anti-tachycardia pacing (atp) therapy followed by a 41 joule device shock for a ventricular arrhythmia.The device shock exhibited an associated shock fault due to a low out of range right ventricular (rv) lead shock impedance value.The shock impedance value was reported as less than 20 ohms, which means the measured shock impedance was less than the minimum value, too low for a numerical result.The device subsequently attempted 26 times to charge for an additional shock, but all attempts failed, exhibiting shock faults and aborted shock attempts due to high voltage and the episode ended.There were 10 subsequent non-sustained ventricular episodes where no device therapy was provided.Ts noted that these stored episodes showed an agonal rhythm and functional undersensing of the degrading electrical signal.Boston scientific engineering also reviewed the stored episode with device therapy.Engineering indicated that the 41 joule shock appears to have damaged the crt-d device resulting in the numerous subsequent high voltage faults during attempted charging.The internal damage resulted in energy leakage during charging which the device sensed as external energy, even though there were no external shock attempts.It was recommended that the crt-d device and rv lead be returned to boston scientific for analysis.The crt-d device and rv lead were returned and have been received at boston scientific.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INOGEN X4 CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key17455009
MDR Text Key320367831
Report Number2124215-2023-41397
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526534577
UDI-Public00802526534577
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010012/S341
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date04/10/2017
Device Model NumberG146
Device Catalogue NumberG146
Device Lot Number370091
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/02/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/24/2023
Initial Date FDA Received08/03/2023
Supplement Dates Manufacturer Received10/30/2023
Supplement Dates FDA Received11/07/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/10/2015
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age71 YR
Patient SexMale
-
-